Addendum to NICE guideline CG61, irritable bowel syndrome in adults diagnosis and management of irritable bowel syndrome in primary care
The NICE guideline on irritable bowel syndrome (IBS) in adults (NICE guideline CG61) was published in 2008. A further two areas were identified where there was evidence suggesting that newer treatments for IBS should be included: the use of linaclotide and lubiprostone in constipation predominant IB...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[London]
National Institute for Health and Care Excellence
2015, February 2015
|
| Edition: | Final version |
| Series: | NICE guideline
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The NICE guideline on irritable bowel syndrome (IBS) in adults (NICE guideline CG61) was published in 2008. A further two areas were identified where there was evidence suggesting that newer treatments for IBS should be included: the use of linaclotide and lubiprostone in constipation predominant IBS (IBS-C) management; and the use of the low FODMAP (fermentable oligosacchardies, disaccahrides, monosaccharides and polyols) diet in IBS management. Consultation with IBS topic-specific members of the update Committee during the development of the review protocol further identified that the use of some psychological interventions (computerised CBT and mindfulness therapy) in the management of IBS should also be updated |
|---|---|
| Physical Description: | 1 PDF file (319 pages) illustrations |